>
Government Free Money Accounts for 19 Percent of All Personal Income
Trump Admin Shuts Down Massive $66 Million Food Stamp Fraud Scheme
State Department Claims The U.S. Will Apply "Maximum Pressure" On Russia
Hydrogen Gas Blend Will Reduce Power Plant's Emissions by 75% - as it Helps Power 6 States
The Rise & Fall of Dome Houses: Buckminster Fuller's Geodesic Domes & Dymaxion
New AI data centers will use the same electricity as 2 million homes
Is All of This Self-Monitoring Making Us Paranoid?
Cavorite X7 makes history with first fan-in-wing transition flight
Laser-powered fusion experiment more than doubles its power output
Watch: Jetson's One Aircraft Just Competed in the First eVTOL Race
Cab-less truck glider leaps autonomously between road and rail
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
Top medical experts are raising alarm bells over the discovery of fibrous, prion-like clots in the blood of young children born to mothers who received the COVID-19 mRNA injections during pregnancy.
Dr. Kevin McCairn, PhD – a respected systems neuroscientist with over 25 years of experience in neurodegenerative disease modeling – has published explosive findings that could shatter the mainstream narrative surrounding the so-called "safe and effective" COVID vaccines, Slay News reported.
His new sentinel report contains what is believed to be the first-ever documented case of amyloid fibrils—a misfolded, prion-like protein—in the blood of a chronically ill 3-year-old child exposed in utero to Pfizer's mRNA shot.
According to PubMed, amyloid fibrils are insoluble protein aggregates associated with deadly neurodegenerative diseases like Alzheimer's and Parkinson's.
These fibrils were detected in the child's blood using Thioflavin T staining, a specialized fluorescent dye. The structures showed alarming signs of misfolded fibrin — a pathological variant linked to abnormal blood clotting and systemic inflammation.
According to McCairn's Substack:
The child was born prematurely at 35 weeks gestation, one week after the mother's second dose of the BNT162b2 (Pfizer) mRNA vaccine. The child was delivered without vital signs and required emergency resuscitation. The severe temporal correlation suggests a significant adverse maternal-fetal reaction.
Over the subsequent three years, the child experienced recurrent immune dysfunction, including tonsillectomy and multiple surgeries for persistent middle ear infections. An unusual frequency of common infectious illnesses and impaired immune responses prompted further investigation into systemic pathologies.
Whole blood samples were analyzed using fluorescence microscopy with Thioflavin T (ThT) staining and SEM. In both imaging modalities, fibrillar structures with amyloid characteristics were identified.
Dr. McCairn believes the clotting is not isolated and is urging an immediate halt and investigation into all mRNA use during pregnancy.